Literature DB >> 23832292

An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus.

Etheresia Pretorius1, Jenny du Plooy, Prashilla Soma, Armen Yuri Gasparyan.   

Abstract

The study suggests that patients with systemic lupus erythematosus (SLE) present with distinct inflammatory ultrastructural changes such as platelets blebbing, generation of platelet-derived microparticles, spontaneous formation of massive fibrin network and fusion of the erythrocytes membranes. Lupoid platelets actively interact with other inflammatory cells, particularly with white blood cells (WBCs), and the massive fibrin network facilitates such an interaction. It is possible that the concerted actions of platelets, erythrocytes and WBC, caught in the inflammatory fibrin network, predispose to pro-thrombotic states in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23832292     DOI: 10.1007/s00296-013-2817-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

Review 1.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

Review 2.  Circulating microparticles: pathophysiology and clinical implications.

Authors:  Andrea Piccin; William G Murphy; Owen P Smith
Journal:  Blood Rev       Date:  2006-11-22       Impact factor: 8.250

3.  Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production.

Authors:  Ionita C Ghiran; Mark L Zeidel; Sergey S Shevkoplyas; Jennie M Burns; George C Tsokos; Vasileios C Kyttaris
Journal:  Arthritis Rheum       Date:  2011-02

Review 4.  Inflammation-induced thrombosis: mechanisms, disease associations and management.

Authors:  Kenan Aksu; Ayhan Donmez; Gokhan Keser
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 5.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Karen M J Douglas; George D Kitas
Journal:  Rheumatol Int       Date:  2011-02       Impact factor: 2.631

6.  Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus.

Authors:  Takashi Satoh; Yoko Tanaka; Yuka Okazaki; Junichi Kaburaki; Yasuo Ikeda; Masataka Kuwana
Journal:  Rheumatology (Oxford)       Date:  2012-06-19       Impact factor: 7.580

7.  Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus.

Authors:  Antoni Hrycek; Paweł Cieślik
Journal:  Rheumatol Int       Date:  2011-02-05       Impact factor: 2.631

8.  Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis.

Authors:  Etheresia Pretorius; Hester Magdalena Oberholzer; Wendy Jeannette van der Spuy; Albe Carina Swanepoel; Prashilla Soma
Journal:  Rheumatol Int       Date:  2011-02-18       Impact factor: 2.631

Review 9.  Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade.

Authors:  George K Bertsias; Jane E Salmon; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

10.  A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.

Authors:  Gerd Gladigau; Philipp Haselmayer; Inge Scharrer; Markus Munder; Nadine Prinz; Karl Lackner; Hansjörg Schild; Pamela Stein; Markus P Radsak
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more
  14 in total

Review 1.  Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.

Authors:  Albe C Swanepoel; Vance G Nielsen; Etheresia Pretorius
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 2.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

3.  Relationship between hyperuricemia and serositis in patients with lupus nephritis.

Authors:  Ping Nie; Liangqian Hu; Bing Li; Yan Lou; Manyu Luo; Yali Wang; Xuehong Lu; Ping Luo
Journal:  Int Urol Nephrol       Date:  2021-05-10       Impact factor: 2.370

Review 4.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

5.  Eryptosis as a marker of Parkinson's disease.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Antoinette V Buys; Natasha Vermeulen; Wiebren Duim; Douglas B Kell
Journal:  Aging (Albany NY)       Date:  2014-10       Impact factor: 5.682

Review 6.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

7.  Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.

Authors:  Etheresia Pretorius; Martin J Page; Sthembile Mbotwe; Douglas B Kell
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

8.  Flow cytometric analysis of platelets type 2 diabetes mellitus reveals 'angry' platelets.

Authors:  Prashilla Soma; Albe Carina Swanepoel; Jeanette Noel du Plooy; Thandi Mqoco; Etheresia Pretorius
Journal:  Cardiovasc Diabetol       Date:  2016-03-31       Impact factor: 9.951

9.  Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity.

Authors:  Janette Bester; Etheresia Pretorius
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

10.  Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.

Authors:  Catalina Burbano; Juan Villar-Vesga; Janine Orejuela; Carlos Muñoz; Adriana Vanegas; Gloria Vásquez; Mauricio Rojas; Diana Castaño
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.